Early trial tests new drug for severe hair loss condition
Disease control
Completed
This early-stage study tested the safety and initial effectiveness of an investigational drug called IMG-007 for adults with alopecia areata who had lost at least 50% of their scalp hair. Participants received three intravenous infusions over four weeks and were followed for 20 w…
Phase: PHASE1, PHASE2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Apr 20, 2026 16:17 UTC